Qingxiao Chen

855 total citations
41 papers, 638 citations indexed

About

Qingxiao Chen is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Qingxiao Chen has authored 41 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Hematology and 15 papers in Oncology. Recurrent topics in Qingxiao Chen's work include Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (8 papers) and Peptidase Inhibition and Analysis (5 papers). Qingxiao Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (8 papers) and Peptidase Inhibition and Analysis (5 papers). Qingxiao Chen collaborates with scholars based in China and United States. Qingxiao Chen's co-authors include Jingsong He, Enfan Zhang, Xi Huang, Li Yang, Zhen Cai, Qing Yi, Donghua He, Zhen Cai, Haimeng Yan and Bao‐Zhen Hua and has published in prestigious journals such as Blood, Oncogene and Scientific Reports.

In The Last Decade

Qingxiao Chen

38 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingxiao Chen China	17	280	164	121	118	69	41	638
Hiroko Fukushima Japan	15	149 0.5×	88 0.5×	55 0.5×	63 0.5×	21 0.3×	89	651
Chithra D. Palani United States	13	317 1.1×	111 0.7×	68 0.6×	27 0.2×	41 0.6×	21	598
Fumihiko Miyoshi Japan	10	204 0.7×	68 0.4×	152 1.3×	85 0.7×	33 0.5×	25	454
Fouzia Siraj India	13	156 0.6×	117 0.7×	72 0.6×	35 0.3×	53 0.8×	83	535
Yuka Kitamura Japan	17	324 1.2×	296 1.8×	85 0.7×	30 0.3×	147 2.1×	62	862
Tingyu Wu China	14	330 1.2×	134 0.8×	49 0.4×	15 0.1×	144 2.1×	52	698
Delfina Costa Italy	16	249 0.9×	192 1.2×	175 1.4×	15 0.1×	98 1.4×	29	663
Teresa Fu United States	14	240 0.9×	245 1.5×	164 1.4×	20 0.2×	32 0.5×	19	894
Claire Martin United Kingdom	22	469 1.7×	213 1.3×	50 0.4×	8 0.1×	49 0.7×	125	1.6k

Countries citing papers authored by Qingxiao Chen

Since Specialization

Citations

This map shows the geographic impact of Qingxiao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxiao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxiao Chen more than expected).

Fields of papers citing papers by Qingxiao Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingxiao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxiao Chen. The network helps show where Qingxiao Chen may publish in the future.

Co-authorship network of co-authors of Qingxiao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qingxiao Chen. A scholar is included among the top collaborators of Qingxiao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingxiao Chen. Qingxiao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Qingxiao, Jiasheng Wang, Yang Yang, et al.. (2024). Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study. Blood. 144(Supplement 1). 7051–7051.

Chen, Jing, Wen Cao, Xi Huang, et al.. (2023). TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood Advances. 7(19). 5752–5770. 12 indexed citations

Cao, Liqin, Qingxiao Chen, Huiyao Gu, et al.. (2022). Chidamide and venetoclax synergistically exert cytotoxicity on multiple myeloma by upregulating BIM expression. Clinical Epigenetics. 14(1). 84–84. 5 indexed citations

Dong, Mengmeng, Jinna Zhang, Qingxiao Chen, et al.. (2022). High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients. Frontiers in Oncology. 12. 936670–936670. 2 indexed citations

Chen, Qingxiao, et al.. (2021). Structuring electronic dental records through deep learning for a clinical decision support system. Health Informatics Journal. 27(1). 1836615492–1836615492. 6 indexed citations

Chen, Qingxiao, et al.. (2020). Clinical decision support model for tooth extraction therapy derived from electronic dental records. Journal of Prosthetic Dentistry. 126(1). 83–90. 25 indexed citations

Yue, Xiaoyan, Qingxiao Chen, & Jingsong He. (2020). Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies. Cancer Cell International. 20(1). 524–524. 38 indexed citations

Yan, Haimeng, Mengmeng Dong, Xinling Liu, et al.. (2019). Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression. Cancer Letters. 446. 38–48. 41 indexed citations

Huang, Xi, Jing Chen, Wen Cao, et al.. (2019). The many substrates and functions of NEDD4-1. Cell Death and Disease. 10(12). 904–904. 77 indexed citations

10.

Xu, Ruyi, Yi Li, Haimeng Yan, et al.. (2019). CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma. Cell Death and Disease. 10(10). 781–781. 42 indexed citations

11.

He, Jingsong, Qingxiao Chen, Huiyao Gu, et al.. (2018). Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease. Haematologica. 103(8). 1369–1379. 21 indexed citations

12.

Yang, Li, Jing Chen, Xiaoyan Han, et al.. (2018). Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway. Protein & Cell. 9(9). 770–784. 15 indexed citations

13.

Guo, Xing, Donghua He, Enfan Zhang, et al.. (2018). HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair. Journal of Experimental & Clinical Cancer Research. 37(1). 205–205. 34 indexed citations

14.

Chen, Jing, Donghua He, Qingxiao Chen, et al.. (2017). BAFF is involved in macrophage-induced bortezomib resistance in myeloma. Cell Death and Disease. 8(11). e3161–e3161. 23 indexed citations

15.

He, Donghua, Xing Guo, Enfan Zhang, et al.. (2016). Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models. Oncotarget. 7(29). 45489–45499. 30 indexed citations

16.

Chen, Qingxiao, Jingsong He, Xing Guo, et al.. (2016). TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression. Blood. 128(22). 5085–5085. 1 indexed citations

17.

Chen, Qingxiao, Ji Wu, Shusen Li, et al.. (2016). An ontology-driven, case-based clinical decision support model for removable partial denture design. Scientific Reports. 6(1). 27855–27855. 41 indexed citations

18.

Xu, Lichen, et al.. (2015). Well-differentiated angiosarcoma of spleen: a teaching case mimicking hemagioma and cytogenetic analysis with array comparative genomic hybridization. World Journal of Surgical Oncology. 13(1). 300–300. 6 indexed citations

19.

Chen, Qingxiao & Bao‐Zhen Hua. (2013). Ultrastructure of dorsal ocelli of the short-faced scorpionfly Panorpodes kuandianensis (Mecoptera: Panorpodidae). Micron. 59. 8–16. 3 indexed citations

20.

Chen, Qingxiao, Wei Yao, & Bao‐Zhen Hua. (2012). Ultrastructural comparison of the compound eyes of Sinopanorpa and Panorpa (Mecoptera: Panorpidae). Micron. 43(8). 893–901. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact